Home › Funds › Enavate Sciences GP, LLC › CAMP
Enavate Sciences GP, LLC position in CAMP
CAMP4 THERAPEUTICS CORP · Health Care
Enavate Sciences GP, LLC reported holding 1,425,541 shares of CAMP (CAMP4 THERAPEUTICS CORP) in its Q2 2026 13F filing — a position valued at US$6.2M, representing 1.80% of its reported portfolio and ranking #7 among its reported holdings. Enavate Sciences GP, LLC has disclosed CAMP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Enavate Sciences GP, LLC's CAMP position evolved
Enavate Sciences GP, LLC first disclosed a stake in CAMP in Q4 2024 at 3,785,802 shares (US$19.8M). Across 7 filings, Enavate Sciences GP, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,425,541 shares valued at US$6.2M — a reduction of -765,379 shares quarter over quarter.. Notable position changes include a 28% trim in Q1 2026 (shares were roughly flat over the following quarter), a 35% trim in Q2 2026 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 3.79M | $19.76M | New |
| Q1 2025 | 3.79M | $15.14M | Hold |
| Q2 2025 | 3.79M | $5.49M | Hold |
| Q3 2025 | 3.79M | $11.36M | Hold |
| Q4 2025 | 3.04M | $18.61M | Reduce |
| Q1 2026 | 2.19M | $9.66M | Reduce |
| Q2 2026 | 1.43M | $6.23M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAMP and 13F data
CAMP (CAMP4 THERAPEUTICS CORP) is a Health Care company. 37 other funds we track also report a position in CAMP — the largest reported positions include 5AM Venture Management, LLC (US$25.6M), Vivo Capital, LLC (US$18.6M), a16z Capital Management, L.L.C. (US$9.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAMP
- 5AM Venture Management, LLC 5.87M sh · $25.65M · Q2 2026
- Vivo Capital, LLC 4.25M sh · $18.56M · Q2 2026
- a16z Capital Management, L.L.C. 2.13M sh · $9.29M · Q2 2026
- Trails Edge Capital Partners, LP 1.93M sh · $8.45M · Q2 2026
- Stonepine Capital Management, LLC 1.39M sh · $6.07M · Q2 2026
- HARBOURVEST PARTNERS LLC 1.27M sh · $5.56M · Q2 2026
More on Enavate Sciences GP, LLC
FAQ
How long has Enavate Sciences GP, LLC held CAMP?
Enavate Sciences GP, LLC has disclosed CAMP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Enavate Sciences GP, LLC's current position in CAMP?
As of Q2 2026, Enavate Sciences GP, LLC holds 1.43M shares of CAMP (CAMP4 THERAPEUTICS CORP), valued at $6.23M, representing 1.80% of its reported portfolio and ranking #7.
Has Enavate Sciences GP, LLC been buying or selling CAMP?
In the latest 13F filing (Q2 2026), Enavate Sciences GP, LLC reduced its position in CAMP.
Which other funds hold CAMP?
Other major institutional holders of CAMP include 5AM Venture Management, LLC, Vivo Capital, LLC, a16z Capital Management, L.L.C., among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.